Minerva Neurosciences, INC. (NERV) — DEF 14A Filings
All DEF 14A filings from Minerva Neurosciences, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Minerva Neurosciences Seeks to Double Authorized Shares, Boost Equity Plan
— Nov 24, 2025 Risk: high
Minerva Neurosciences, Inc. (NERV) is holding its 2025 Annual Meeting on December 22, 2025, virtually, to address several critical proposals impacting its corpo -
Minerva Neurosciences Files Definitive Proxy Statement
— Oct 22, 2024 Risk: low
Minerva Neurosciences, Inc. filed its definitive proxy statement (DEF 14A) on October 22, 2024, for its annual meeting of stockholders. The filing provides deta
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX